Search Results 561-570 of 8030 for TNF
The study will be conducted in three parts. Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or ...
The purpose of this study is to evaluate the performance of the wearable tPatch device when compared to an oral temperature measuring device in patients who ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... tumor necrosis factor (TNF) inhibitor, and/or interleukin 6 (IL-6) blockers. Any active autoimmune disease or chronic inflammatory condition, with the ...
This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...
Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., at Mayo Clinic: Studies modulation of the immune response in viral brain infection.
The aims of this study are: Assess preoperative nutrition status, thyroid function and pathogen colonization; Correlate these assessments with clinical outcomes ...
About this study. This study will establish a repository of stored blood, corneal endothelial and skin fibroblast samples from people with Fuchs endothelial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.